Modern Diagnostic IPO is a book-built issue, the total issue size of which has been kept at ₹36.89 crore. This IPO is a completely fresh issue, in which about 0.41 crore new shares will be offered. The entire amount raised from this issue will be used for the growth plans and operational needs of the company. Bidding of Modern Diagnostic IPO will open on 31 December 2025 and will close on 2 January 2026. The allotment of IPO is likely to be finalized on 5 January 2026. This IPO will be listed on the BSE SME platform, whose tentative listing date has been fixed as 7 January 2026. The price band of the IPO is ₹85–₹90 per share. Lot size is 1,600 shares. The minimum investment for retail investors will be around ₹2.88 lakh.

Zepto IPO: Zepto, a big company in the quick commerce sector, is ready to launch its IPO. Zepto has received approval from its board of directors for an IPO of Rs 11,000 crore. This offer will be a mix of fresh equity issue and offer for sale. Zepto has submitted draft papers for the IPO with market regulator Securities and Exchange Board of India (SEBI). The company plans to debut in the stock market by next year.

Confidential route is becoming famous

With this, Zepto will become the first startup company to be listed in the Indian Stock Exchange. People with knowledge of the matter say that Zepto has submitted a pre-filed draft red herring prospectus with SEBI and the stock exchange through the confidential filing route. The company recently raised $450 million from its investors, taking its total funding to $2.3 billion.

There is a growing trend among companies, especially startups, to submit DRHP with SEBI in a confidential manner for launching IPO. This gives an opportunity to submit important information related to the company to SEBI in the initial phase without making it public. DRHP is made public after receiving feedback from SEBI and completion of preparations at its level. This confidential method is becoming popular among high-growth startups preparing for a big IPO.

Many more companies are in the queue to launch IPO

If the listing goes through, Zepto will join other listed quick-commerce companies Zomato (via Blinkit) and Swiggy (via Instamart), both of which already trade on Indian exchanges. Zomato’s parent company Eternal was listed in 2021, while Swiggy debuted in November 2024.

Just a four-year old company, Zepto had received the green signal from its shareholders to launch an IPO in the general board meeting held on December 23. Earlier, startups like Ola Electric and Honsa Consumer took six-seven years to go public. Many big companies were launched in the year 2025. It is expected that next year will also be great for IPOs. Currently, many companies including PhonePe, Flipkart, ShadowFax, ShipRocket and CureFoods are in the queue to go public.

Also read:

Gold price reached Rs 1.40 lakh for the first time, will the price fall next year or will the price go beyond Rs 1.5 lakh?

Modern Diagnostic & Research Center Limited IPO: Modern Diagnostic & Research Center Limited IPO, a big company in the healthcare and diagnostic sector, is going to launch its IPO. This will be the last IPO of this year. This is a book built issue of Rs 36.89 crore.

This IPO is a completely fresh issue. Modern Diagnostic is coming with its IPO on 31st December, for which investors will be able to bid till 2nd January 2026. Share allotment under the IPO is expected to take place on January 5, 2026. Whereas the company’s stocks can be listed on BSE and NSE on January 7, 2026.

What is the price band?

The company has fixed the price band for the IPO at Rs 85 to Rs 90 per share. There will be 1600 shares in one lot. Retail investors will have to apply for at least two lots i.e. 3200 shares. According to the upper price band, a minimum investment of Rs 2.88 lakh will have to be made for this. At least 3 lots have been reserved for HNI investors in the IPO of Modern Diagnostic and Research Centre.

What does the company do?

Modern Diagnostic and Research Center, a diagnostic service provider, provides testing facilities in segments like forensic pathology, anatomical pathology, molecular pathology. The company also provides radiology services. These include X-Ray, Ultrasound, CT Scan, MRI, Mammography. It has 21 centers in 8 states across the country. Of these, there are 17 laboratories and four diagnostic centres. Started in 1985, this diagnostic chain specializes in diagnosing diseases through medical testing facilities.

For what purpose will the money be used?

The company will use the funds raised from the IPO to purchase medical equipment for its diagnostic centers and laboratories, meet working capital requirements, repay earlier loans and fulfill general corporate purposes.

Disclaimer: (The information provided here is being given for information only. It is important to mention here that investment in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com never advises anyone to invest money here.)

Also read:

Coca-Cola India’s bottling company HCCB is preparing for retrenchment, know how many people will be laid off?

KSH International Limited is bringing a book built IPO of ₹710 crore. This includes Fresh Issue of ₹420 crore (1.09 crore shares) and Offer For Sale of ₹290 crore (0.76 crore shares).

Subscription for IPO will open from 16 to 18 December 2025. Allotment is expected on December 19 and listing is expected on December 23, 2025 on BSE and NSE. Price band has been fixed at ₹365–₹384 per share.

Lot size is 39 shares, with retail investments starting from ₹14,976. The required investment is ₹2.09 lakh for SNII and ₹10.03 lakh for bNII. Book Running Lead Manager is Nuvama Wealth and Registrar is MUFG Intime India.

HRS Aluglaze IPO is a public issue of a growing aluminum solutions company.

The company deals in customized aluminum products like windows, doors, curtain walls and cladding.

Since 2012, it is providing its services to builders, contractors and architects. Talking about financial performance, there has been a continuous strong growth in revenue and PAT, especially the performance in FY25 was much better.

Raising ₹10.02 crore from anchor investors before the IPO shows the confidence of investors. Although it is an SME IPO, there is definitely risk in it, but at the same time the growth potential is also good. This IPO may be worth paying attention to for long-term investors.

Upcoming IPOs in Next Week: The third week of December is starting from 15th. There will be a bustling atmosphere in the stock market this entire week because four public issues worth a total of about Rs 830 crore are going to be launched next week. First of all, investors will get the opportunity to bid for the mainboard offering KSH International. During this period, 15 companies are also going to debut on the exchange, which include big names like ICICI Prudential AMC, Corona Remedies and Park Medi World.

Waiting for the listing of this IPO

Investors are eagerly waiting for the listing of ICICI Prudential AMC next week. This IPO of Rs 10,603 crore, launched on December 12, got a good response on the first day. It got more than 50 percent subscription. The gray market premium (GMP) of the IPO is Rs 255, which is 10.39 percent more than the issue price. The last day to bid for the IPO is December 16. Other mainboard segment listings include Corona Remedies,

In other mainboard listings, there is discussion about Corona Remedies, whose GMP is 31.07 percent more than the issue price. Meanwhile, Nephrocare’s GMP is 6.52 percent, which shows moderate listing expectations. After this there is Wakefit, whose GMP is nominal at 2.05 percent. At the same time, in the SME segment, GMP of KV Toys is 63.18 percent and this is indicating a strong listing.

KSH International IPO

In the mainboard segment, KSH International is coming out with its public issue on Tuesday, 16th December, which will close on Thursday, 18th December. The price band for the IPO has been fixed between Rs 365 to Rs 384 per share. Its size is around Rs 710 crore and the company’s shares will be listed on both BSE and NSE. KSH International, managed by Nuwama Wealth Management, is the biggest IPO to open next week and is expected to support the overall sentiment in the primary market.

Of the amount raised from IPO, it will use Rs 226 crore to repay the loan. Rs 87 crore will be spent in purchasing new machinery and technology for Supa and Chakan plants. Apart from this, Rs 8.8 crore will be spent on setting up rooftop solar power plant in Supa unit. The remaining amount will be spent on general corporate needs.

Disclaimer: (The information provided here is being given for information only. It is important to mention here that investment in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com never advises anyone to invest money here.)

Also read:

Transformer manufacturing company got 2 big orders, investors broke on shares; Know how much the price rose?

Upcoming IPO: There is going to be a wave of IPOs in the Indian stock market in the trading week starting from Monday 8th December. Due to which movement can be seen in the stock market. Between 8th and 12th December, many companies are launching their IPOs in the market. Through which the company will try to raise money.

This week, IPOs of 4 mainboard companies and 5 SME companies are opening. Due to which investors can have many options to invest. Let us know which companies’ IPOs are opening this week…

1.Corona Remedies

The IPO of Corona Remedies is opening today i.e. 8th December, which will remain open till 10th December. The company will try to raise Rs 655.37 crore through IPO. The price band of shares has been fixed at Rs 1,008 to Rs 1,062. The company has kept the lot size of 14 shares. The IPO is completely offered for sale. The company may be listed in the stock market on December 15.

2. Nephrocare Health Services

The IPO of Nephrocare Health Services will be open between December 10 and December 12. The company will try to raise Rs 871.05 crore through IPO. Under which new shares worth Rs 353.4 crore will be issued.

At the same time, Rs 517.64 crore will be for offer for sale. The company has fixed the price band of shares between Rs 438 and Rs 460. One lot size will be 32 shares. The company may be listed in the market on December 17.

3.Wakefit Innovations

The public issue of Wakefit Innovations will be open for investors between 8 and 10 December. The company is trying to raise Rs 1,288.89 crore through IPO. The price band of the share has been fixed at Rs 85 to Rs 195. There will be a lot size of 76 shares.

The company will issue fresh shares worth Rs 377.18 crore and offer for sale worth Rs 911.71 crore under the IPO. The company may be listed in the stock market on December 15.

4. Park Medi World

The IPO of Park Medi World will be open for investors between 10 and 12 December. The company is bringing fresh shares worth Rs 770 crore and offer for sale worth Rs 150 crore under IPO. The price band has been fixed at Rs 154 to Rs 162. It is estimated that the company will be listed in the stock market on December 17.

Disclaimer: (The information provided here is being given for information only. It is important to mention here that investment in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com never advises anyone to invest money here.)

Also read: Stock Market Today: Weak start of the stock market, Sensex fell by 82 points, Nifty below 26,172.

Meesho IPO: E-commerce platform Meesho (Meesho IPO) is also all set to enter the stock market. The IPO of SoftBank-invested company Meesho will open for subscription on December 3, on which investors will be able to place bets till December 5, 2025.

This is one of the most talked about and biggest public issues of 2025. The IPO of Rs 5421.05 crore includes fresh issue of Rs 4250 crore and offer for sale of 10.55 crore shares. The company has also announced the price band for the IPO, which has been fixed at Rs 105-111 per share.

How much share reserved for whom?

For Meesho’s IPO, investors will have to bid for 135 shares in one lot. For anchor investors, this IPO will open a day earlier i.e. on Tuesday, December 2. Allocation for anchor investors takes place a day before the issue opens. The issue will be managed by Kotak Mahindra Capital Company, JP Morgan India, Morgan Stanley India Company, Axis Capital and Citigroup Global Markets India, while Kfin Technologies Limited will act as the registrar.

Of the total size of Meesho’s public issue, at least 75 percent is reserved for QIBs, up to 15 percent for NIIs and up to 10 percent for retail investors. Shares will be allotted on Monday, December 8, while the refund process will start from Tuesday, December 9 and shares will be credited to the demat account on the same day of refund. The shares are expected to be listed on BSE and NSE by Wednesday, December 10.

How much is GMP?

Investors were waiting for Meesho’s IPO for a long time. Its effect is visible in the gray market premium. According to market experts, the unlisted shares of Meesho Limited are currently trading at a premium of Rs 144 per share in the gray market, while the upper price band of the IPO is Rs 111. This means that the gray market premium (GMP) is around 30 percent, which indicates its strong listing.

Disclaimer: (The information provided here is being given for information only. It is important to mention here that investment in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com never advises anyone to invest money here.)

This too Read:

Gold becomes expensive again, price rises by Rs 700 in a day; Know what is the price of 10 grams?

PhysicsWallah IPO: The IPO of the country’s well-known online education platform Physicswallah is going to open next week on 11th November. To launch this IPO of Rs 3480 crore, Red Herring Prospectus (RHP) has been submitted to the Registrar of Companies. Anchor investors will be able to bid for this on November 10. Bets can be placed in the issue till November 13. Shares will be allotted by 14th November, while from 18th November the shares will be listed on BSE and NSE.

Including both fresh issue and OFS

Let us tell you that Physicswala is an education platform, which provides preparation for competitive exams both online and offline. The company’s IPO has both fresh issue and offer-for-sale. New shares worth Rs 3,100 crore will be issued in this issue, while promoters like Alakh Pandey and Prateek Boob will sell shares worth Rs 380 crore under the OFS window.

According to media reports, Alakh Pandey and Prateek Boob will sell shares worth Rs 190 crore through OFS. Both of them currently have 40.31 percent stake in the company. This Noida-based company had filed draft papers for the IPO with SEBI in March through the confidential pre-filing route and after getting the green signal from market regulator SEBI in July, the company submitted an updated DRHP in the month of September before submitting the RHP.

What will the company do with the money?

Physicswala has said that out of the amount raised from the IPO, Rs 460.5 crore will be spent on building new offline and hybrid centers and Rs 548.3 crore will be spent on lease payments. Apart from this, Rs 47.2 crore will also be invested in the subsidiary company Xylem Learning. Of these, Rs 31.6 crore are spent on new centers and Rs 15.5 crore are spent on lease payments and hostels.

Rs 33.7 crore will be given to Utkarsh Classes and Edutech for lease payment of its centres. Apart from this, Rs 200.1 crore is to be spent for server and cloud infrastructure, Rs 710 crore in marketing and Rs 26.5 crore to buy additional stake in Utkarsh Classes.

The journey started in 2020

Alakh Pandey and Prateek Maheshwari started Physicswala in 2020 as an edtech platform. First of all, he provides preparation for NEET, JEE Mains, NCERT and BITSAT through his YouTube channel. During that time, previous years’ question papers of these exams were made available to help the students so that they could prepare accordingly. Today the number of its registered students is more than 35 lakh. It has more than 78 lakh subscribers on YouTube. The rating of the app is also 4.8.

Disclaimer: (The information provided here is being given for information only. It is important to mention here that investment in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com never advises anyone to invest money here.)

Also read:

Impact of American injury! India is going to make huge cut in Russian crude oil by the end of November

Pine Labs IPO: Fintech unicorn Pine Labs is coming with its IPO on 7th November. The company is preparing to raise Rs 2,080 crore through fresh issue. Apart from this, 8.23 ​​crore shares will be sold under Offer for Sale (OFS). In this way the issue size will be approximately Rs 3,500 crore. The closing of the issue will take place on 11 November. Anchor investors will be able to bid on 6 November.

This company, which competes with companies like Paytm, Razorpay, Infibeam, PayU Payments and Phonepe in its country and companies like Adyen, Shopify and Block in the global market, submitted draft papers in June, which got approval from SEBI on September 11. The price band per share for the IPO will be announced on Monday. Share allotment is to be done on 12th November and listing can happen on BSE, NSE on 14th November.

Disclaimer: (The information provided here is being given for information only. It is important to mention here that investment in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com never advises anyone to invest money here.)

Also read:

This stock of Adani can go up to Rs 187, why is the brokerage’s trust on the stock unwavering?